TY - JOUR
T1 - The Role of Magnetic Resonance Elastography in the Diagnosis of Noncirrhotic Portal Hypertension
AU - Navin, Patrick J.
AU - Gidener, Tolga
AU - Allen, Alina M.
AU - Yin, Meng
AU - Takahashi, Naoki
AU - Torbenson, Michael S.
AU - Kamath, Patrick S.
AU - Ehman, Richard L.
AU - Venkatesh, Sudhakar K.
N1 - Funding Information:
Conflicts of interest Richard L. Ehman and Meng Yin and the Mayo Clinic have intellectual property rights and a financial interest related to magnetic resonance elastography technology. The remaining authors disclose no conflicts. Funding This study was partially supported by NIH grant EB001981 (RLE) and NIH grant EB017197 (MY).
Funding Information:
Funding This study was partially supported by NIH grant EB001981 (RLE) and NIH grant EB017197 (MY).
Publisher Copyright:
© 2020 AGA Institute
PY - 2020/12
Y1 - 2020/12
N2 - Portal hypertension (PH) is defined as abnormal elevation of portal venous pressure with cirrhosis accounting for 90% of cases and 10% of cases classified as noncirrhotic PH (NCPH).1,2 The differentiation of cirrhotic PH (CPH) from NCPH is difficult (Supplementary Figure 1), with recent research efforts focusing on noninvasive evidence of increased hepatic stiffness.3,4 Magnetic resonance elastography (MRE) is an established imaging technique in the assessment of hepatic stiffness, and is now the most efficacious, noninvasive method to assess for hepatic fibrosis.5–8 The aim of this study was to assess the ability of magnetic resonance imaging (MRI) and MRE to differentiate between CPH and NCPH.
AB - Portal hypertension (PH) is defined as abnormal elevation of portal venous pressure with cirrhosis accounting for 90% of cases and 10% of cases classified as noncirrhotic PH (NCPH).1,2 The differentiation of cirrhotic PH (CPH) from NCPH is difficult (Supplementary Figure 1), with recent research efforts focusing on noninvasive evidence of increased hepatic stiffness.3,4 Magnetic resonance elastography (MRE) is an established imaging technique in the assessment of hepatic stiffness, and is now the most efficacious, noninvasive method to assess for hepatic fibrosis.5–8 The aim of this study was to assess the ability of magnetic resonance imaging (MRI) and MRE to differentiate between CPH and NCPH.
UR - http://www.scopus.com/inward/record.url?scp=85096202786&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85096202786&partnerID=8YFLogxK
U2 - 10.1016/j.cgh.2019.10.018
DO - 10.1016/j.cgh.2019.10.018
M3 - Short survey
C2 - 31629882
AN - SCOPUS:85096202786
SN - 1542-3565
VL - 18
SP - 3051-3053.e2
JO - Clinical Gastroenterology and Hepatology
JF - Clinical Gastroenterology and Hepatology
IS - 13
ER -